The expression levels of bone morphogenetic proteins 2 and 4 (BMP2 and BMP4), both have been suggested to play important roles in tumour metastasis, showed a 10 and 14 fold decrease by rosiglitazone, respectively. The gene discussed is BMP2; the disease is neoplasm.